Encompass Health Corporation (NYSE:EHC) Shares Sold by DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale trimmed its holdings in Encompass Health Corporation (NYSE:EHC - Free Report) by 39.0% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,605 shares of the company's stock after selling 3,588 shares during the period. DekaBank Deutsche Girozentrale's holdings in Encompass Health were worth $560,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also modified their holdings of the company. GAMMA Investing LLC raised its position in shares of Encompass Health by 21.5% in the first quarter. GAMMA Investing LLC now owns 2,366 shares of the company's stock valued at $240,000 after buying an additional 419 shares during the last quarter. OneDigital Investment Advisors LLC acquired a new stake in shares of Encompass Health in the first quarter valued at about $263,000. Sequoia Financial Advisors LLC raised its position in shares of Encompass Health by 6.7% in the first quarter. Sequoia Financial Advisors LLC now owns 2,727 shares of the company's stock valued at $276,000 after buying an additional 172 shares during the last quarter. Cambridge Investment Research Advisors Inc. increased its position in Encompass Health by 30.1% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 9,597 shares of the company's stock worth $972,000 after purchasing an additional 2,218 shares during the last quarter. Finally, Fifth Third Bancorp increased its position in Encompass Health by 88.7% during the first quarter. Fifth Third Bancorp now owns 4,290 shares of the company's stock worth $434,000 after purchasing an additional 2,017 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. KeyCorp raised their price objective on shares of Encompass Health from $122.00 to $135.00 and gave the stock an "overweight" rating in a research report on Tuesday, May 27th. Truist Financial restated a "buy" rating and set a $135.00 price objective (up from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. UBS Group lifted their price target on shares of Encompass Health from $117.00 to $130.00 and gave the company a "buy" rating in a research report on Monday, April 28th. Stephens upgraded shares of Encompass Health from an "overweight" rating to a "strong-buy" rating and set a $135.00 price target for the company in a research report on Thursday, June 5th. Finally, Royal Bank Of Canada lifted their price target on shares of Encompass Health from $110.00 to $125.00 and gave the company an "outperform" rating in a research report on Monday, April 28th. Seven research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Buy" and an average price target of $131.50.

Encompass Health Trading Up 0.9%

NYSE EHC opened at $118.50 on Monday. The firm has a 50 day simple moving average of $119.58 and a 200-day simple moving average of $106.36. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.06 and a current ratio of 1.06. Encompass Health Corporation has a one year low of $82.74 and a one year high of $123.13. The firm has a market cap of $11.95 billion, a price-to-earnings ratio of 24.48, a PEG ratio of 2.41 and a beta of 0.88.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a net margin of 8.97% and a return on equity of 17.63%. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same quarter last year, the firm posted $1.12 earnings per share. The business's revenue for the quarter was up 10.6% compared to the same quarter last year. Equities research analysts anticipate that Encompass Health Corporation will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a $0.17 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a yield of 0.57%. Encompass Health's dividend payout ratio is currently 14.05%.

Insider Buying and Selling

In related news, CEO Mark J. Tarr sold 118,384 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $121.53, for a total value of $14,387,207.52. Following the completion of the transaction, the chief executive officer owned 527,070 shares in the company, valued at $64,054,817.10. The trade was a 18.34% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Elissa Joy Charbonneau sold 4,279 shares of Encompass Health stock in a transaction that occurred on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total transaction of $498,974.19. Following the completion of the transaction, the insider owned 11,958 shares of the company's stock, valued at $1,394,422.38. This represents a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold 132,663 shares of company stock worth $16,034,082 over the last 90 days. 2.10% of the stock is owned by insiders.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.